More importantly, our results showed a significant association between the expression levels of PDE5 and CXCL16 in the stroma of breast cancer patients and a statistically significantly poorer overall survival in patients with high PDE5 and high CXCL16 levels compared with all other patients. Here, PDE5A is linked to breast carcinoma.